Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Hepatol Res. 2015 Mar 24;45(13):1292–1298. doi: 10.1111/hepr.12505

Table II.

Interferon therapy and SVR rates

Treatment information Total treated
(n=36)
Genotype 1
(n=13)
Genotype 2
(n=12)
Genotype 3
(n=11)
SVR , (%) 20 (55.6%) 5 (38.5%) 7 (58.3%) 8 (72.7%)
Relapse/no response (%) 16 (44.4%) 8 (61.5%) 5 (41.6%) 3 (27.2%)

SVR †- Sustained viral response